Quantitative gene expression of somatostatin receptors and noradrenaline transporter underlying scintigraphic results in patients with neuroendocrine tumors.

Medicine & Life Sciences

• Norepinephrine Plasma Membrane Transport Proteins 100%
• Somatostatin Receptors 89%
• Neuroendocrine Tumors 78%
• somatostatin receptor 2 58%
• Gene Expression 41%
• Radionuclide Imaging 37%
• 3-Iodobenzylguanidine 32%
• Octreotide 18%
• somatostatin receptor 5 12%
• indium-111-octreotide 12%
• somatostatin receptor type 1 12%
• Pentetic Acid 10%
• Molecular Imaging 9%
• Colorectal Neoplasms 6%
• Real-Time Polymerase Chain Reaction 6%
• Adenocarcinoma 6%
• Down-Regulation 5%